The Global status report on road safety 2023 shows that the number of annual road traffic deaths has fallen slightly to 1.19 million. Road traffic deaths and injuries remain a major global health and development challenge. As

India topped countries in the South-East Asia region for the most number of malaria cases and deaths in 2022, according to this report published by the World Health Organization (WHO).

The world is confronted with a global food crisis fueled by conflict, climate change and the COVID-19 pandemic. Meanwhile, tobacco is grown in over 124 countries, taking up millions of hectares of fertile land that could be used to grow food, address food security and nutrition challenges and help feed families.

The overall maternal mortality rate dropped by 34.3 per cent over a 20-year period -- from 339 maternal deaths per 100,000 live births in 2000 to 223 maternal deaths in 2020, according to this report by the World Health Organization and other UN agencies.

This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022).

The publication provides a comprehensive update on the status and key actions needed for providing reliable, modern energy to health-care facilities in low- and middle-income countries.

The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.

HIV drug resistance (HIVDR) can compromise the effectiveness of antiretroviral therapy (ART) in reducing HIV incidence and HIV-associated morbidity and mortality. Minimizing the spread of HIVDR is a critical aspect of the broader global response to antimicrobial resistance.

The year 2021 marks 100 years since the momentous discovery of insulin in 1921, which marked a turning point in care for those with diabetes. Over the past century, better health outcomes for people living with diabetes have been incrementally achieved.

This report describes the potential financial outcomes that can be expected from successful development of a GBS vaccine that can attain global registration. The report also assesses whether specific additional financing is required to support the clinical development activities.